The 17th Annual World Vaccine Congress is the place where the global vaccine industry meets to discuss commercial and scientific issues around regulation, strategy, manufacturing, trials, partnering, influenza, cancer, emerging diseases and veterinary vaccines.
Across 150 sessions, you will learn from leading experts across the issues most impacting on the wider vaccine sector, as well as delve into your specialist area of research and job focus in co-located conferences.
Meet over 700 of your peers in one room and take advantage of the multiple extended networking breaks, co-located World Vaccine Congress (including 7 streams on Immune Profiling, Cancer & Immunotherapy, Influenza & Respiratory, Clinical Trials, Emerging Diseases, Partnerships, Veterinary Vaccines and Bioprocessing & Manufacturing) as well as the evening drinks reception.
Build three days of totally tailored content and attendees!
Following on from the highly successful World Vaccine Congress series in Washington DC and Europe for the past 18 years, the San Diego event will offer learning and business development opportunities taking advantage of the rich biotech and funding environment that the west coast offers.
The focus will be on the vaccines industry in general, but also more specifically on integrating the technologies revolutionising immunotherapy and its impact on vaccine development.
Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, at the 18th annual World Vaccine Congress, 3rd World Veterinary Vaccine Congress and 2nd Immune Profiling World Congress, we have content, networking and potential partners for you.
By bringing experts from the whole value chain under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.
Take just three days out of the office to meet with 450+ potential customers who need to find solutions to challenges around the commercial and scientific issues in manufacturing, trials, strategy, regulation, veterinary, immune profiling, respiratory, therapeutic and emerging diseases vaccines
Dr Gregory A. Poland
Director of Mayo Vaccine Research Group
Dr Cyril Gay
Senior National Program Leader, Office of National Programs
Dr George Siber
CSO of ClearPath Vaccines & Chair of Scientific Advisory Board, Genocea Bioscience Inc
Dr. Leonard Friedland
VP, Scientific Affairs and Public Health Vaccines, North America
Dr Peter Hotez
President of the Sabin Vaccine Institute and Dean of National School of Tropical Medicine, Baylor College of Medicine
Prof Stanley Plotkin
University of Pennsylvania School of Medicine
Prof Bali Pulendran
Professor in the Department of Pathology and Laboratory Medicine
Emory University School of Medicine
Director of Vaccine Development, Global Health Program
Bill and Melinda Gates Foundation
Dr Alessandro Sette
Center Head, Division Head, and Professor Center for Infectious Disease
La Jolla Institute
Dr Jerald Sadoff
Senior Advisor to CEO
Janssen Infectious Diseases and Vaccines
Prof Mark Davis
the Burt and Marion Avery Family Professor, Microbiology & Immunology
"Super networking event. Very professionally organised. High calibre delegates."
“Most productive vaccine-focused meeting of the year.”
Director, Research & Development
"Very well planned and executed event. A credit to the team that pulled it all together."
Business Development and Marketing
"Superb speakers, excellent location, excellent networking time built into the schedule"
Director of Mayo Vaccine Research
Group Mayo Clinic and Foundation
"Great organization, great talks, relevant delegate profiles"
"The event was a great mixture of academic and applied industry session along with updates and insights into clinical trials and policy."
Director, Vaccine Process Development